Core Viewpoint - The article discusses a pending securities class action against Ardent Health, Inc. and its executives, focusing on allegations of misleading accounting practices and failure to disclose critical financial information [1][3]. Group 1: Allegations and Financial Impact - The litigation centers on Ardent's use of a 180-day cliff for reserving uncollectible accounts, which allegedly contradicts previous claims of using detailed reviews for receivables valuation [3][7]. - A significant $54 million increase in professional liability reserves was reported, which, along with the accounting practices, led to a 33% drop in stock price [3][7]. - On November 12, 2025, Ardent disclosed a transition to a new accounting method that resulted in a revenue reduction of $42.6 million, further impacting investor confidence [7]. Group 2: Legal Proceedings and Next Steps - The lead plaintiff deadline for the class action is set for March 9, 2026, prompting investors to consider their losses [1][6]. - Hagens Berman, the law firm handling the case, is actively advising investors who purchased shares between July 18, 2024, and November 12, 2025 [5][6]. - The firm encourages whistleblowers with non-public information to come forward, potentially benefiting from the SEC Whistleblower program [6].
ARDT DEADLINE ALERT: Ardent Health (ARDT) Investors Alerted to Today's Lead Plaintiff Deadline in Securities Class Action - Hagens Berman